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Abstract
The objective of this study was to investigate if long-term clearance from small airways is dependent
on normal ciliary function.
Six young adults with primary ciliary dyskinesia (PCD) inhaled 111 Indium labelled Teflon particles
of 4.2 µm geometric and 6.2 µm aerodynamic diameter with an extremely slow inhalation flow,
0.05 L/s. The inhalation method deposits particles mainly in the small conducting airways. Lung
retention was measured immediately after inhalation and at four occasions up to 21 days after
inhalation. Results were compared with data from ten healthy controls. For additional comparison
three of the PCD subjects also inhaled the test particles with normal inhalation flow, 0.5 L/s,
providing a more central deposition. The lung retention at 24 h in % of lung deposition (Ret24) was
higher (p < 0.001) in the PCD subjects, 79 % (95% Confidence Interval, 67.6;90.6), compared to 49
% (42.3;55.5) in the healthy controls. There was a significant clearance after 24 h both in the PCD
subjects and in the healthy controls with equivalent clearance. The mean Ret24 with slow inhalation
flow was 73.9 ± 1.9 % compared to 68.9 ± 7.5 % with normal inhalation flow in the three PCD
subjects exposed twice. During day 7–21 the three PCD subjects exposed twice cleared 9 % with
normal flow, probably representing predominantly alveolar clearance, compared to 19 % with slow
inhalation flow, probably representing mainly small airway clearance.
This study shows that despite ciliary dysfunction, clearance continues in the small airways beyond
24 h. There are apparently additional clearance mechanisms present in the small airways.
Introduction
Inhaled insoluble particles deposited in the lung are
cleared by various clearance mechanisms depending on
the site of deposition. Three different compartments
within the lung can be distinguished, the large airways
including the main lobar and segmental bronchi; the
small airways representing mainly the bronchioles; and
the alveolar region. These three compartments might also
represent three different clearance phases. The majority of
particles deposited in the large airways of healthy subjects
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are eliminated within 24 h by the mucociliary clearance
mechanism, and it has long been assumed that any parti-
cles remaining in the lung at 24 h represent alveolar clear-
ance [1,2]. This is probably due to the deposition pattern
of particles inhaled with normal inhalation flow which
give a limited deposition in the small airways. However,
previous studies in healthy subjects using a shallow bolus
technique as well as studies using extremely slow inhala-
tion flow (0.05 L/s) and 6 µm particles, resulting in parti-
cles deposited in the small airways, show that a
considerable fraction of particles may be retained after 24
h [3-5]. This slow clearance phase, probably representing
the small airways, continues and is shown to be faster
than the alveolar clearance but much slower than clear-
ance from the large airways. The slow clearance phase has
now been included in the revised dosimetric model for
the human respiratory tract adopted by the ICRP [6], rep-
resenting clearance of particles deposited in the bronchi-
olar region.
Primary ciliary dyskinesia (PCD) is an inherited auto-
somal recessive disorder, characterized by absent or
impaired mucociliary transport due to ciliary movement
dysfunction. The disorder is clinically manifested by
chronic respiratory tract infections beginning in early
childhood, leading to chronic bronchitis, chronic rhinos-
inuitis and otitis media as well as by situs inversus in 50
% of the affected subjects and male infertility [7,8].
Histopathological studies have shown that early morpho-
logical changes, i.e signs of an inflammatory process, first
appear in the small airways in several lung diseases such
as asthma, chronic bronchitis and cystic fibrosis [9,10]. It
is not clear which mechanisms contribute to the clearance
from the small airways. In an earlier study clearance from
small airways was studied up to 96 h, in six subjects with
PCD. The retained fraction at 24 h reflecting the large air-
way was larger compared to that of the healthy controls. A
significant clearance occurred in the PCD subjects every
24 h up to 72 h, but after 72 h the clearance declined, but
was still faster than alveolar clearance [11]. It is possible
that the first 72 h in the PCD subjects reflected clearance
from the whole lung, both large, middle and some small
sized airways, with a prolonged fast clearance phase repre-
senting cough clearance which serves as a compensatory
mechanism for their defective MCC. The slower clearance
after 72 h probably represents clearance from small air-
ways since it is unlikely that cough can compensate in this
region. Even in patients with chronic bronchitis, faster
clearance than alveolar clearance occurs from the small
airways: [12].
So far, few studies investigating clearance from the small
airways have been published since there are limitations in
the technique of depositing particles in these airways. One
option is to use rather large monodisperse particles (6
µm) and an extremely slow inhalation flow (0.05 L/s), in
which the major inhaled fraction will be deposited in the
small ciliated airways. A recently performed study in
patients with cystic fibrosis has shown that clearance from
small airways did not significantly differ from that of the
healthy subjects [13]. Studies in PCD patients provide a
unique possibility to investigate the clearance mechanism
with defective MCC from the small airways.
The aim of this study was to investigate whether long term
clearance from the small airways is dependent on normal
ciliary function. We defined the small airways using the
morphological data from the Weibel model A [14], gener-
ations 9–15, corresponding to the terminal bronchioles,
which have ciliated epithelium and are less than 2 mm in
diameter. The observation period after the first days was
used to discriminate between small airway clearance and
large airway clearance. Our hypothesis was that clearance
from small airways is dependent on normal mucociliary
transport.
Materials and methods
Subjects and design
Long-term clearance (up to 21 days) from small airways
was studied in six non-smoking subjects (two females)
with primary ciliary dyskinesia, mean age 23.5 (range:
15–35) yrs, recruited from the paediatric pulmonary
department and Stockholm CF-center at Karolinska Uni-
versity Hospital and compared with previous data from
ten non-smoking healthy controls [15]. The PCD subjects
had clinical and radiological evidence of bronchiectases;
three of them had situs inversus totalis. The subjects with-
out situs inversus were examined with nasal or bronchial
brush biopsies, and ciliary ultrastructural abnormalities
were proven by electron microscopic studies [16]. The
PCD subjects were in clinically stable condition during
the study, although subj. no 5 completed an i.v. antibiotic
treatment at the beginning of the study initiated at signs
of low grade infection. There was a significant difference
in FEV1 and airway resistance between the PCD subjects
and the healthy controls (p < 0.05). Otherwise the groups
did not differ. Characteristics of the participating subjects
and their lung function data are given in table 1.
All subjects inhaled 6 µm monodisperse Teflon particles
labelled with 111In with an extremely slow inhalation flow
(ESI), 0.05 L/s, giving deposition mainly in the small air-
ways. Radioactivity over the mouth, throat, lungs and
stomach was measured immediately after the inhalation
of the test particles. Lung retention was measured at 24
hrs, 7, 14 and 21 days. Correction was made for back-
ground activity and physical decay of the radionuclide. To
confirm results from our previous study we let three of the
PCD subjects (no 1–3) inhale the similar test particles alsoRespiratory Research 2006, 7:79 http://respiratory-research.com/content/7/1/79
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with normal inhalation flow, 0.5 L/s, giving a more cen-
tral deposition [17]. This exposure was performed one
month after the first exposure. Lung retention was meas-
ured at equal time points as the ESI exposure. The regional
deposition data were estimated using a model developed
at the Karolinska Institutet. In the evaluation of the data,
the studied period was divided into two phases. A first fast
clearance phase, defined as clearance between 0 and 24
hrs, representing mainly large and medium sized airways,
and, a second slow clearance phase, defined as clearance
between 24 hrs and day 21, representing mainly small air-
ways. Since clearance after 24 hrs up to one week could
include cough clearance from larger airways, a longer
study of 7 to 21 days was chosen to represent small airway
clearance.
The study was approved by the Ethics Committee of
Human Research and the Isotope Committee at the Karo-
linska University Hospital. All the PCD and the healthy
subjects have given their written informed consent to par-
ticipate in the study. Parental consent was obtained for
the subjects younger than 18 years.
Lung function tests
The pulmonary function was evaluated the same day as
the exposure by forced expirograms (Lung Function Labo-
ratory 2100, SensorMedics, Anaheim, CA, USA) giving
forced vital capacity (FVC), forced expiratory volume in 1
s (FEV1.0), and forced expiratory flow between 25 and
75% of the exhaled volume (FEF25–75%). Airway resistance
(Raw), was measured using a panting technique within a
whole-body plethysmograph (Transmural Body Box
2800, SensorMedics). The subjects wore a noseclip and
performed the tests in a sitting position. All lung function
parameters were determined according to the criteria pro-
posed by Quanjer [20].
Production and inhalation of test particles
The Teflon particles were produced using the same batch
of colloidal Teflon and labelled with 111Indium (half-life
68 h) by a spinning disc technique [21]. The reprocessing
of the particles before inhalation has been described else-
where [22]. Mean particle size was 6.2 µm, with a geomet-
ric standard deviation of 1.07. The mean aerodynamic
diameter was calculated from the density of the Teflon
particles, 2.12 g/cm3, as measured by Philipson [21]. The
calculated aerodynamic diameter of the Teflon particles
was also confirmed by direct measurements of the settling
velocity in air [23]. The subjects wore a noseclip and
inhaled the particles in a sitting position. The subjects first
made a moderately deep exhalation outside the chamber
and then inhaled as deep as they could from the chamber.
The inhalation flow was measured with a pneumotacho-
graph, placed between the aerosol chamber and the
mouthpiece, and was displayed on-line. By looking at the
recorder needle, the subjects could inhale at a fairly con-
stant rate throughout the inspiration. All subjects were
trained to inhale in this manner before they inhaled the
test particles. Between each inhalation from the chamber,
the subject could rest and breathe quietly. During the
inhalation from the chamber, the PCD subjects had no
problem of voluntarily suppressing potential coughs.
Measured inhalation flow varied between 0.043–0.049 L/
s for all the subjects. The duration of the exposure with
Table 1: Anthropometric and lung function data. Individual data are given for the subjects with PCD and mean data are given for the 
healthy controls.
Subject 
no.
Sex Age(yrs) Weight(kg) Height(cm) Situs inversus Drug 
regimen
FVC %preda FEV1 %preda FEV1/FVC % RawkPa*s*L-1
1 F 31 64 175 No IB 108 94 76 0.143
2 M 15 69 176 Yes IB OM OA 126 116 84 0.101
3 M 16 47 164 Yes IB OM OA 98 87 81 0.182
4 F 19 56 168 Yes Non 92 83 79 0.230
5 M 35 80 183 No IB IM OM 92 57 51 0.251
6 M 23 83 182 No IB, IM 94 75 67 0.220
Mean 23.5 66.5 175 102 85 73,2 0.245
SD 8.3 13.8 7 13 20 11,4 0.073
Healthy 
controls
n = 10
Mean 6M/4F 22.3 73.1 176 109 106 84,1 0.144
SD 1.9 11.7 7 17 13 6,8 0.032
M; male, F; female. a) Predicted values according to Quanjer [20].: IB; inhaled bronchodilatator, IM; inhaled mucolytics, OM; oral mucolytics, OA; 
profylactic oral antibiotic.Respiratory Research 2006, 7:79 http://respiratory-research.com/content/7/1/79
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slow inhalation flow was on average 6 min and the dura-
tion of each breath lasted about 30 s, during which all par-
ticles deposited by means of sedimentation. Exhaled
radioactivity has earlier been shown to be 0–2% [19]. In
the exposure with normal inhalation flow, the flow was
measured to 0.45–0.48 L/s and each inhalation included
a breath hold of at least 2 sec after full inspiration.
Measurement of radioactivity
Immediately after inhalation and 24 hours later, the radi-
oactivity was measured using two 127 × 51 mm NaI crys-
tals fitted with collimatorsc. The radioactivity deposited in
the lungs was 0.1 MBq. The radioactivity was also meas-
ured at 24 hours and at 7 days after inhalation using the
whole-body scanner with three large NaI detectors, at the
Swedish Radiation Protection Institute (SSI)[4]. The front
of each detector facing the subject was provided with
focusing slit collimators of lead. The γ-spectra from each
detector were acquired separately giving a total of 210
spectra from one measurement. The spectra were later
analysed so that the radioactivity in the lung could be dis-
tinguished from the activity in the stomach. The tech-
nique has been described in detail by Falk et al [18]. At
day 7, 14 and 21, when the radioactivity in the gastroin-
testinal tract was insignificant compared to the lung radi-
oactivity, a more sensitive lung counter with the subject in
supine position was used. The relative sensitivity between
the lung counter and the whole-lung scanner at 24 h, and
between the whole-lung scanner and the low-level lung
counter at day 7 was established for each subject by
repeated measurements in the two systems within an
hour.
Lung retention was measured with the same procedure in
the three subjects exposed with normal inhalation flow.
Statistical analyses
The data were analysed statistically using SPSS 11.0 for
Windows. The descriptive data are expressed as mean ± SD
and the results as mean (95% confidence interval (CI))
when appropriate. Nonparametric rank sum test for eval-
uation of differences between the groups and the Spear-
man correlation coefficient were used; p < 0.05 was
considered significant. In the few cases when the meas-
ured point differed by 1 day, measurements were adjusted
at 2 and 3 weeks using interpolation to day 14 and 21.
Results
Deposition
The calculated regional deposition in different airway gen-
erations with the extremely slow inhalation flow, accord-
ing to the theoretical model, showed that the main
fraction was deposited in the small airways (in genera-
tions 9–15: 54–62%), i.e the bronchiolar region. Calcula-
tion for the PCD subjects and the healthy controls showed
similar deposition pattern with only a small fraction (16–
22 %) deposited in the alveolar region. With normal inha-
lation flow a substantially larger fraction of the particles in
the three subjects exposed was deposited in the large air-
ways (mean 74%, mouth and throat excluded). With nor-
mal inhalation flow only 14% of total deposition was
calculated to be deposited in the small airways, Figure 1.
Fast airway clearance
A significant larger lung retention at 24 h in percentage of
the initial lung deposition (Ret24) was found in the PCD
subjects, 79 % (95% CI 67.6;90.6), compared to the
healthy subjects, 49 % (42.3;55.5), p < 0.001. A difference
in lung retention compared to the healthy subjects per-
sisted through out the study (p < 0.005) to the last meas-
ured point at day 21, Table 2 and Figure 2.
Slow airway clearance
Both in the PCD subjects and in the healthy controls there
was significant difference in retention between each time
point indicating a significant measured clearance contin-
uing in the small airways in both groups. Overall, the slow
clearance phase between day 1 and day 21 did not differ
significantly between the PCD subjects and the healthy
controls (Figure 3). There was no correlation between
FEV1 and Raw with Ret24 or clearance between day 7 to day
21. Also the subject who completed an i.v. antibiotic treat-
ment during the study did not differ significant from the
average clearance pattern, e.g. was not in the outer range.
The Ret24 was not significantly larger for particles inhaled
at 0.05 L/s, (75, 75 and 72%) compared to 0.5 L/s (76, 61,
69%) in the three PCD subjects (p = 0.28). With normal
flow, 0.5 L/s, only 9% of the fraction retained at day 7 was
cleared the following two weeks, compared to 19% with
the extremely slow inhalation flow, Figure 4.
Discussion
Clearance in the small airways is difficult to study, most of
all since deposition in this region is difficult to target. The
objective of this study was to investigate long-term clear-
ance from small airways in subjects with a known ciliary
dysfunction and to compare their clearance data with data
from healthy controls. The design of the study with PCD
subjects studied over a longer period was 1) to select a
population with known defective ciliary function and 2)
to ascertain that clearance from large to middle size air-
ways was completed.
Deposition
In this study we used rather large particles inhaled with
extremely slow inhalation to maximize deposition in the
small airways. The advantage of the method is that
regional deposition is independent in respect to airway
constriction, since the extremely slow inhalation flowRespiratory Research 2006, 7:79 http://respiratory-research.com/content/7/1/79
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decreases impaction and the deposition is mainly due to
sedimentation [24]. Extremely slow inhalation probably
also reduces deposition by impaction in areas with bron-
chiectases. The predicted lung deposition of the inhaled
particles was to a large extent in the small airways. Our
model for regional deposition predicted very small differ-
ences between the PCD subjects and the healthy controls
(Figure 1), even if there was a difference in FEV1 and air-
way resistance between the PCD subjects and the healthy
controls. The significantly larger retention day 1 (Ret24) in
the PCD subjects compared to the healthy controls (Fig-
ure 2) also indicates deposition mainly in the small air-
ways, a result which is in agreement with our earlier study
in PCD subjects [11]. Particles deposited more centrally in
the lung would be effectively cleared from large airways by
coughing, resulting in a smaller difference of the Ret24
compared to the healthy controls [11,17]. If the fraction
of particles instead had been to a larger extent deposited
in the alveolar region, the clearance after 24 h would have
been much slower than what was found. The alveolar
clearance of insoluble particles (similar to ours) has been
shown to be very slow and may take years to complete
[25]. We therefore conclude that the particles were depos-
ited to a larger extent in the small airways as suggested
from estimates using the model developed at the Karolin-
ska Institutet [4,5,18,19] both in the PCD subjects as well
as in the healthy controls.
Fast airway clearance
Normally, the fast airway clearance is concluded within
24 h in healthy subjects shown in studies both with
extremely slow and normal inhalation techniques [1]. For
4.2 µm aerodynamic diameter ferromagnetic iron oxide
particles inhaled with the shallow bolus technique,
approximately 50 % of the deposited fraction clears by the
fast mucociliary clearance mechanism with a mean clear-
ance half life of 3.0 ± 1.6 h [26]. Our data shows the same
result among the healthy subjects, with a cleared fraction
of 51% within 24 h (Table 2 and Fig 2). However, in the
PCD subjects there was a substantial fraction retained at
24 h (Ret24), 79.1 ± 10.9, showing that the fast airway
clearance was prolonged due to impaired mucociliary
clearance depending on ciliary dysfunction. Similar find-
ings have been reported by Regnis et al measuring muco-
ciliary clearance with gamma scintigraphy up to 24 h in
PCD patients [27]. In the present study the fast clearance
phase continued in the PCD subjects up to one week
(Table 2, Fig 2). Similar result was also found by our
group in patients with CF, using the same design as in this
study [13]. Also the recently published study by Möller et
al [28], measuring clearance up to 270 days using ferro-
magnetic particles inhaled with the shallow bolus tech-
nique, indicated a prolonged fast clearance phase
measured at 1, 2 and 7 days in the PCD patients. In the
earlier study with the same type of particles and slow
inhalation technique by Svartengren et al [11], the clear-
ance among PCD subjects measured every 24 h up to 96 h
showed that the fast clearance phase was prolonged up to
72 h : Even if the patients with CF and PCD, of our studies,
have daily inhalations and physiotherapy the voluntary
coughing could only partially compensate for their defec-
tive MCC. To establish an effective cough clearance, suffi-
cient high velocity of airflow is needed, which can only be
obtained in the larger tracheobronchial region approxi-
mately down to generation 7, together with a productive
mucus production [29,30].
The impaired MCC, predominantly affecting the fast
clearance phase, probably has impact on the progression
of the disease. After being diagnosed of PCD and with the
introduction of a treatment program, most of the patients
lung function is stabilized [31]. This shows that appropri-
ate use of antibiotics and mucus dissolving agents,
together with effective airway clearance techniques, e.g.
physiotherapy, is effective enough to keep the fast clear-
ance phase within the basic needs. Despite the apparent
similarities with CF, PCD has a much better prognosis.
The progression of the lung damage in CF is probably due
to the mucus properties with reduced local immunologi-
cal response rather than the mucociliary movement dys-
function [32].
Calculated regional deposition in percentage of total deposi- tion of 6µm particles (Dae) inhaled with extremely slow inha- lation flow (0.05 L/s) in ten healthy controls  and six  subjects with PCD ■  in large airways (BB, generations 0–8),  small airways (bb, generations 9–15) and alveolar region (alv,  generations 16–23) according to the airway model proposed  by Weibel 14 Figure 1
Calculated regional deposition in percentage of total deposi-
tion of 6µm particles (Dae) inhaled with extremely slow inha-
lation flow (0.05 L/s) in ten healthy controls  and six 
subjects with PCD ■  in large airways (BB, generations 0–8), 
small airways (bb, generations 9–15) and alveolar region (alv, 
generations 16–23) according to the airway model proposed 
by Weibel 14. For comparison 3 PCD subjects inhaled 6µm 
particles with normal inhalation flow (0.5 L/s) І.
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Slow airway clearance
In healthy subjects, the slow clearance phase, using the
shallow bolus deposition technique, was shown to have a
half life of 109 ± 78 days measured over a period of 9
month [26]. However, some of the ferromagnetic particles
in the study could have reached the alveolar region and
the result may represent both small airways and alveolar
clearance. Previous clearance studies using the extremely
slow inhalation technique and particle size as in this
study, in both healthy subjects and various groups of
patients, have shown a slow clearance phase continuing
for several weeks with kinetics faster than alveolar but also
clearly different from large airway clearance [25,33].
The present study focused on clearance from the small air-
ways in patients with a known ciliary dysfunction (PCD),
investigating whether normal mucociliary transport is
necessary for clearance in the small airways. The results
show that the mean cleared fraction between 24 h and 7
days in percent of the available fraction at 24 h was 27%
in the PCD subjects and 28% in the healthy controls. The
small airway clearance was equivalent for the PCD sub-
jects and the healthy controls, using either day 1 or day 7
as starting point for the slow airways clearance up to the
last measured point at 21 days (Figure 3). In support to
our findings, the study by Möller et al showed that after
the prolonged fast clearance phase was concluded, there
was no difference in the fraction of long-term retained
particles between the PCD patients and the healthy sub-
jects [28]. The PCD subjects ultrastructual abnormalities
have been shown to correlate to low cilia activity scores.
[34] Even if the PCD subjects may have some ciliary
movements, our results suggest that MCC is less impor-
tant in the small airways and that other mechanisms than
MCC apparently are present and probably responsible for
a substantial clearance. This hypothesis is also supported
by a study using adrenergic stimulation. Normally, terbu-
taline stimulates MCC [35], but no increased clearance
from small airways was found in healthy controls when
pre-stimulating MCC by oral intake of terbutaline and
then inhaling the test particles [36]. All but one of the
PCD subjects were treated with brochodilatator during the
study. The subject (no 4) with no treatment had a retained
fraction at 24 h of 98 %, subsequently 15 % of the
The mean retention of 6 µm particles (Dae) in percentage of  retention at 24 hrs in six subjects with PCD and ten healthy  controls, using an extremely slow inhalation flow, 0.05 L/s Figure 3
The mean retention of 6 µm particles (Dae) in percentage of 
retention at 24 hrs in six subjects with PCD and ten healthy 
controls, using an extremely slow inhalation flow, 0.05 L/s. 
The bars show the SD of the mean.
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Table 2: Particle retention in percent of deposition (mean, ± SD) at 24 h, 7, 14 and 21 days after exposure.
All PCD n = 6 Healthy controls n = 10 Normal flow 0.5 l/s n = 3 Slow flow 0.05 l/s n = 3
Ret24h 79.1 ± 10.9* 48.9 ± 9.3* 68.6 ± 7.5 73.9 ± 1.6
Ret7d 57.9 ± 16.2** 35.3 ± 8.8** 42.1 ± 8.7 50.8 ± 6.9
Ret14d 53.5 ± 17.2** 29.7 ± 9.1** 40.2 ± 8.7 45.5 ± 6.5
Ret21d 49.9 ± 17.6** 27.2 ± 8.4** 38.1 ± 8.6 41.2 ± 7.4
*: p < 0.001 ** p < 0.01 for the PCD patients versus reference data from healthy controls using Mann-Whitney rank sum test.
The mean retention of 6 µm particles (Dae) in percentage of  deposition in six subjects with PCD and ten healthy controls  using an extremely slow inhalation flow, 0.05 L/s Figure 2
The mean retention of 6 µm particles (Dae) in percentage of 
deposition in six subjects with PCD and ten healthy controls 
using an extremely slow inhalation flow, 0.05 L/s. The bars 
show the SD of the mean. Significant difference a) p < 0.001, b) 
p < 0.005, c) p < 0.01 comparing retention between the two 
studied groups.
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retained particles at 24 h cleared within 21 days. It is pos-
sible that MCC stimulating agents together with cough
clearance are most important for the fast clearance phase,
representing the larger airways. In the smaller airways the
airflow is much slower due to the large cross-sectional
area and consequently cough clearance is less effective.
But cough could, as a mechanical force, influence other
secondary mechanisms in the small airways. The only
stimulating effect on clearance from small airways docu-
mented so far is continuous positive airway pressure ther-
apy (CPAP) in children with Duchennes muscular
dystrophy [37]. Increasing age has also been shown to
have a negative association to slow airway clearance meas-
ured between 1–21days [15].
The clearance is highly dependent on where the particles
deposit; in large airways; small airways or in the alveolar
region. With normal inhalation flow, the particles deposit
partly in the larger airways and partly in the alveolar non-
ciliated region. This difference between normal and slow
inhalation flow is illustrated in the three subjects who
inhaled the test particles also with normal inhalation
flow. A slightly lower Ret24 (69%) was shown using the
normal inhalation flow, compared to the slow inhalation
flow (74%), in the three subjects.
With more centrally deposition the fast clearance phase,
representing above all cough clearance in the PCD sub-
jects, continued after 24 h with an average cleared frac-
tion, between 24 h and day 7, of 39% of Ret24. After day 7
the clearance turned very slow, representing mainly alve-
olar clearance, and the average cleared fraction between
day 7 to day 21, in percentage of remained fraction day 7,
was only 9% compared to 19% with slow inhalation flow
(Figure 4).
Other possible clearance mechanisms besides MCC in the
small airways could be phagocytosis by airway macro-
phages or penetration to the sub-mucus space between
the cilia. Airway macrophages are rapidly recruited to the
sites of the particle deposition and phagocytose the parti-
cles [38]. The more loaded the macrophages are, the more
rapidly they disappear from the conducting airways [39].
In vivo particle uptake by airway macrophages in healthy
subjects showed a maximal uptake at 100 min after aero-
sol inhalation suggesting that a resident population of
macrophages is present on the airway surface [40]. If this
really reflects the macrophage action in small airways has
however not been verified since the sampling of the parti-
cles and macrophages in this study was with induced spu-
tum method derived from the larger airways [41]. The
thickness of the mucous layer varies by location in the
conducting airways, and has been reported to be 8.3 µm
in the trachea to about 1.8 µm in the small bronchioles.
There are evidence that the mucus layer in the small bron-
chi and bronchioles is consisting of discontinues patches
rather than a continuous layer [42]. The particles are
coated with surfactant and then submerge and penetrate
to the aqueous layer between the cilia where they can be
engulfed both by macrophages and by dentritic cells [43].
Penetration of particles through the epithelium is proba-
bly more important for smaller particles than those used
in the present study, although new evidence indicates lim-
ited translocation and elimination from the lung also for
ultrafine particles [44].
Conclusion
The purpose of this study was to investigate if mucociliary
transport as a mechanism has a significant importance for
the clearance in the small airways. Subjects with primary
ciliary dyskinesia were chosen since they have a known
ciliary dysfunction. Even though the number of included
PCD subjects in this study was small, it was shown that
rather large particles, inhaled with an extremely slow
inhalation flow, resulted in increased deposition in small
airways equal to the healthy controls according to the
model calculation. The larger deposited fraction in the
small airways, however, resulted in larger lung retention
at 24 h and a prolonged fast clearance phase in the PCD
subjects due to their defective MCC and could not be com-
pensated by cough clearance. The slow airway clearance
after 24 h continued faster than alveolar clearance despite
their defective ciliary function. The clearance from small
airways in the PCD subjects, measured as lung retention
day 1–21, had similar clearance rate as the healthy con-
trols. This study does not support the hypothesis that
clearance from small airways is dependent on normal cil-
The mean retention of 6 µm particles (Dae) in percentage of  retention at 24 h in three of the PCD subjects with  extremely slow inhalation flow, 0.05 L/s (full drawn line), and  with normal flow, 0.5 L/s (dotted line) Figure 4
The mean retention of 6 µm particles (Dae) in percentage of 
retention at 24 h in three of the PCD subjects with 
extremely slow inhalation flow, 0.05 L/s (full drawn line), and 
with normal flow, 0.5 L/s (dotted line). The bars show the SD 
of the mean.
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iary function only. There are apparently additional mech-
anisms acting in the small airways. The small airways that
constitute of a transitional zone between the tracheobron-
chial and the alveolar region still remain an unknown
area. Further investigation about other possible clearance
mechanisms acting in the small airways is needed.
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